Investor Presentation - First Nine Months of 2016

Investor presentation First nine months of 2016 Slide 109 Stable ownership structure secured through A and B-share structure Share structure Novo Nordisk Foundation Novo A/S 75.3% of votes 27.5% of capital A shares 537m shares Institutional and private investors 24.7% of votes 72.5% of capital B shares 2,013m shares Novo Nordisk A/S Note: Treasury shares are included in the capital but have no voting rights changing diabetes® • • The Novo Nordisk Foundation The Novo Nordisk Foundation is a self-governing institution that: • provides a stable basis for Novo Nordisk supports scientific, humanitarian and social purposes All strategic and operational matters are governed by the board and management of Novo Nordisk Overlapping board memberships ensure that the Novo Nordisk Foundation and Novo Nordisk share vision and strategy novo nordisk

View entire presentation